These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21228927)

  • 21. BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper.
    Rodriguez FJ; Ligon AH; Horkayne-Szakaly I; Rushing EJ; Ligon KL; Vena N; Garcia DI; Cameron JD; Eberhart CG
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):789-94. PubMed ID: 22892521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern.
    Ida CM; Lambert SR; Rodriguez FJ; Voss JS; Mc Cann BE; Seys AR; Halling KC; Collins VP; Giannini C
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):631-9. PubMed ID: 22710963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.
    Rodriguez EF; Scheithauer BW; Giannini C; Rynearson A; Cen L; Hoesley B; Gilmer-Flynn H; Sarkaria JN; Jenkins S; Long J; Rodriguez FJ
    Acta Neuropathol; 2011 Mar; 121(3):407-20. PubMed ID: 21113787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.
    Idoate MA; Soria E; Lozano MD; Sola JJ; Panizo A; de Alava E; Manrique M; Pardo-Mindán FJ
    Diagn Mol Pathol; 2003 Sep; 12(3):160-5. PubMed ID: 12960698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.
    Ebinger M; Senf L; Wachowski O; Scheurlen W
    Pediatr Hematol Oncol; 2005; 22(1):83-7. PubMed ID: 15770836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
    Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
    Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.
    Jacob K; Albrecht S; Sollier C; Faury D; Sader E; Montpetit A; Serre D; Hauser P; Garami M; Bognar L; Hanzely Z; Montes JL; Atkinson J; Farmer JP; Bouffet E; Hawkins C; Tabori U; Jabado N
    Br J Cancer; 2009 Aug; 101(4):722-33. PubMed ID: 19603027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.
    Gutmann DH; McLellan MD; Hussain I; Wallis JW; Fulton LL; Fulton RS; Magrini V; Demeter R; Wylie T; Kandoth C; Leonard JR; Guha A; Miller CA; Ding L; Mardis ER
    Genome Res; 2013 Mar; 23(3):431-9. PubMed ID: 23222849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.
    Yu J; Deshmukh H; Gutmann RJ; Emnett RJ; Rodriguez FJ; Watson MA; Nagarajan R; Gutmann DH
    Neurology; 2009 Nov; 73(19):1526-31. PubMed ID: 19794125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.
    Ho CY; Bar E; Giannini C; Marchionni L; Karajannis MA; Zagzag D; Gutmann DH; Eberhart CG; Rodriguez FJ
    Neuro Oncol; 2013 Jan; 15(1):69-82. PubMed ID: 23161775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS; Yuan M; Imada EL; Ames H; Marchionni L; Gutmann DH; Rodriguez FJ
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):96-107. PubMed ID: 32603552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
    Reis GF; Bloomer MM; Perry A; Phillips JJ; Grenert JP; Karnezis AN; Tihan T
    Mod Pathol; 2013 Oct; 26(10):1279-87. PubMed ID: 23702730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
    Kluwe L; Hagel C; Tatagiba M; Thomas S; Stavrou D; Ostertag H; von Deimling A; Mautner VF
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):917-20. PubMed ID: 11556548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
    Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
    Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.
    Sharma MK; Mansur DB; Reifenberger G; Perry A; Leonard JR; Aldape KD; Albin MG; Emnett RJ; Loeser S; Watson MA; Nagarajan R; Gutmann DH
    Cancer Res; 2007 Feb; 67(3):890-900. PubMed ID: 17283119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
    von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
    Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular and cell biology of pediatric low-grade gliomas.
    Chen YH; Gutmann DH
    Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.